Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

OBJECTIVE: To investigate whether methotrexate (MTX) has a steroid sparing effect in the treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). METHODS: We carried out a randomised double blind, placebo controlled study in 40 patients with PMR, six of whom also had clinical sympto...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Ann Rheum Dis
Principais autores:	van der Veen, M J, Dinant, H J, van Booma-Frankfort, C, van Albada-Kuipers, G A, Bijlsma, J W
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1010141/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8733437/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.55.4.218
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!